Finding your next opportunity shouldn’t require piecing together multiple databases, alerts and research tools.
Fundz combines its own funding and M&A intelligence with hiring, leadership and other business signals into one connected view of each company, ranks opportunities against your ideal customer profile, and delivers the evidence and verified contacts to act on. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
ADARx Pharmaceuticals, Inc.
The company signed a major contract or deal. An 8-K is the notice a US public company must file within four business days of a major event.
www.adarx.comAI Executive Summary
AI-powered analysis of 8-K filing content
ADARx Pharmaceuticals completed a $100 million private placement with AbbVie Inc. concurrent with its IPO on September 28, 2026, providing significant capital and signaling strategic validation from a major pharmaceutical partner.
Key Takeaways
AbbVie invested $100 million for approximately 5,255,542 shares at $17.00 per share in a private placement agreement signed September 13, 2026
The transaction closed simultaneously with ADARx's IPO on September 28, 2026, demonstrating strong institutional confidence
1 more takeaway
Filing Overview
What This Means
ADARx Pharmaceuticals, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.